UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 288

Sortiert nach

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Journal of thoracic oncology, 2014-02, Vol.9 (2), p.195-199

2014

Volltextzugriff (PDF)

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy‐naive patients with extensive‐disease small cell lung cancer

Cancer, 2010-01, Vol.116 (1), p.132-136

2010

Volltextzugriff (PDF)

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

Lung cancer (Amsterdam, Netherlands), 2009-02, Vol.63 (2), p.219-226

2009

Volltextzugriff (PDF)

A Phase II Study of I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Clinical Medicine Insights. Oncology, 2023-12, Vol.17

2023

Volltextzugriff (PDF)

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Clinical Medicine Insights. Oncology, 2023-01, Vol.17, p.11795549231218082-11795549231218082

2023

Volltextzugriff (PDF)

Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma

Asia-Pacific journal of clinical oncology, 2023-12, Vol.19 (6), p.690-696

2023

Volltextzugriff (PDF)

Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer

Psycho-oncology (Chichester, England), 2014-11, Vol.23 (11), p.1300-1306

2014

Volltextzugriff (PDF)

The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Molecular cancer research, 2009-10, Vol.7 (10), p.1736-1743

2009

Volltextzugriff (PDF)

Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer

Japanese journal of clinical oncology, 2005-12, Vol.35 (12), p.720-726

2005

Volltextzugriff (PDF)

BRCA1 Gene Mutation in Thymic Malignant Melanoma

The Annals of thoracic surgery, 2013-08, Vol.96 (2), p.677-680

2013

Volltextzugriff (PDF)

Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma

Clinical transplantation, 2007-05, Vol.21 (3), p.337-343

2007

Volltextzugriff (PDF)

Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer

Annals of thoracic medicine, 2017-01, Vol.12 (1), p.36-41

2017

Volltextzugriff (PDF)

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation

Blood Research, 2015, 50(2), , pp.114-117

2015

Volltextzugriff (PDF)

CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib

Journal of cancer research and therapeutics, 2012-04, Vol.8 (2), p.247-253

2012

Volltextzugriff (PDF)

Medullary Thyroid Carcinoma with Ectopic Adrenocorticotropic Hormone Syndrome

Endocrinology and Metabolism, 2014, 29(1), , pp.96-100

2014

Volltextzugriff (PDF)

Evaluation of Adrenal Masses in Lung Cancer Patients Using F-18 FDG PET/CT

Nuclear Medicine and Molecular Imaging , 2011, 45(1), , pp.52-58

2011

Volltextzugriff (PDF)

Synchronous multiple primary lung cancers with different response to gefitinib

Lung cancer (Amsterdam, Netherlands), 2006-08, Vol.53 (2), p.245-248

2006

Volltextzugriff (PDF)

18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non–Small Cell Lung Cancer

Clinical cancer research, 2008-04, Vol.14 (7), p.2036-2041

2008

Volltextzugriff (PDF)

Association of Epidermal Growth Factor Receptor Mutations with Metastatic Presentations in Non-Small Cell Lung Cancer

ISRN oncology, 2011-01, Vol.2011, p.756265-6

2011

Volltextzugriff (PDF)

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer

Journal of Korean medical science, 2007-09, Vol.22 Suppl (Suppl), p.S115-S121

2007

Volltextzugriff (PDF)

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study

Annals of nuclear medicine, 2008-10, Vol.22 (8), p.645-651

2008

Volltextzugriff (PDF)

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer

Journal of Korean Medical Science, 2007, 22(3), , pp.393-399

2007

Volltextzugriff (PDF)

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis

Journal of cancer research and clinical oncology, 2017-11, Vol.143 (11), p.2283-2290

2017

Volltextzugriff (PDF)

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia

Annals of hematology, 2006-05, Vol.85 (5), p.285, Article 285

2006

Volltextzugriff (PDF)

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Clinical Medicine Insights. Oncology, 2023, Vol.17, p.11795549231218082

2023

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(283)

Publikationsform

Artikel
(287)
Tagungsberichte
(1)

Sprache

Japanisch
(14)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy‐naive patients with extensive‐disease small cell lung cancer

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

A Phase II Study of I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma

Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer

The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer

BRCA1 Gene Mutation in Thymic Malignant Melanoma

Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma

Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation

CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib

Medullary Thyroid Carcinoma with Ectopic Adrenocorticotropic Hormone Syndrome

Evaluation of Adrenal Masses in Lung Cancer Patients Using F-18 FDG PET/CT

Synchronous multiple primary lung cancers with different response to gefitinib

18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non–Small Cell Lung Cancer

Association of Epidermal Growth Factor Receptor Mutations with Metastatic Presentations in Non-Small Cell Lung Cancer

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Aktive Filter

Suchergebnisse filtern